The number of patients diagnosed with cardiomyopathy has increased substantially over the past two decades. This is the ...

For Derek Johnson of Lethbridge, Alta., the signs of a heart problem piled up slowly. At first, too slowly to alarm him. Derek became winded mowing the lawn. He had trouble concentrating at work. But ...

with the Disease, Inspired by the Experience with HCM of ...

Cytokinetics is committed to supporting patients with MYQORZO & You™, a personalized program for patients prescribed MYQORZO ...

Taking the medication mavacamten for HCM can reduce obstruction in your heart. Learn about its benefits, risks, and side ...

A multicentre study shows AI-enabled ECG screening can be integrated into clinical workflows to detect previously undiagnosed hypertrophic cardiomyopathy and accelerate follow-up.

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incor ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Dr Anand Ramamurthy explains how lifestyle diseases impact organ transplant outcomes and why careful risk assessment can still make complex surgeries possible.

U.S. track & field star Sydney McLaughlin-Levrone opens up on her pregnancy, her dad's heart disease and a potential Olympic double at the 2028 Games.

Men face higher risk of cardiovascular disease earlier than women, so heart health awareness, prevention and early detection are key decades sooner than many may think.

Rugby star Uini Atonio's heart attack – at the age of 35 – has ruined his chances of playing in France's Six Nations opener; ...